516.85 5.55 (1.09%)
10.2M XNYS Volume
XNYS 21 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Michele J. Hooper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2025 | 152 | 39,932 (0%) | 0% | 0 | Common Stock | |
| Paul R. Garcia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2025 | 6 | 2,302 (0%) | 0% | 0 | Common Stock | |
| Stephen J. Hemsley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2025 | 31 | 706,819 (0%) | 0% | 0 | Common Stock | |
| Andrew P. Witty | Director, CEO, UHG | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2025 | 114 | 112,162 (0%) | 0% | 0 | Common Stock | |
| Timothy Patrick Flynn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2025 | 38 | 8,943 (0%) | 0% | 0 | Common Stock | |
| Charles D. Baker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2025 | 4 | 803 (0%) | 0% | 0 | Common Stock | |
| Erin L. McSweeney | EVP & Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2025 | 25 | 11,206 (0%) | 0% | 0 | Common Stock | |
| Thomas E. Roos | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2025 | 14 | 29,499 (0%) | 0% | 0 | Common Stock | |
| John F. Rex | President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2025 | 75 | 186,621 (0%) | 0% | 0 | Common Stock | |
| John H. Noseworthy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2025 | 24 | 5,583 (0%) | 0% | 0 | Common Stock | |
| Valerie Montgomery Rice | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2025 | 24 | 6,076 (0%) | 0% | 0 | Common Stock | |
| Kristen L. Gil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2025 | 4 | 1,443 (0%) | 0% | 0 | Common Stock | |
| F. William McNabb | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2025 | 30 | 13,473 (0%) | 0% | 0 | Common Stock | |
| Heather R. Cianfrocco | Chief Executive Officer, Optum | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2025 | 46 | 22,438 (0%) | 0% | 0 | Common Stock | |
| Christopher Zaetta | EVP & Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2025 | 28 | 10,307 (0%) | 0% | 0 | Common Stock | |
| Timothy John Noel | Chief Executive Officer, UHC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2025 | 27 | 9,196 (0%) | 0% | 0 | Common Stock | |
| Andrew P. Witty | Director, CEO, UHG | Payment of exercise price or tax liability using portion of securities received from the company at price $ 466.50 per share. | 20 Feb 2025 | 1,315 | 112,048 (0%) | 0% | 466.5 | 613,450 | Common Stock |
| Andrew P. Witty | Director, CEO, UHG | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 15,652 | 111,871 (0%) | 0% | 0 | Common Stock | |
| Andrew P. Witty | Director, CEO, UHG | Payment of exercise price or tax liability using portion of securities received from the company at price $ 502.45 per share. | 20 Feb 2025 | 7,356 | 104,515 (0%) | 0% | 502.5 | 3,696,023 | Common Stock |
| Andrew P. Witty | Director, CEO, UHG | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 11,445 | 115,960 (0%) | 0% | 0 | Common Stock | |
| Andrew P. Witty | Director, CEO, UHG | Payment of exercise price or tax liability using portion of securities received from the company at price $ 466.48 per share. | 20 Feb 2025 | 1,364 | 114,595 (0%) | 0% | 466.5 | 636,273 | Common Stock |
| Andrew P. Witty | Director, CEO, UHG | Payment of exercise price or tax liability using portion of securities received from the company at price $ 466.57 per share. | 20 Feb 2025 | 1,232 | 113,363 (0%) | 0% | 466.6 | 574,816 | Common Stock |
| Andrew P. Witty | Director, CEO, UHG | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 48,540 | 48,540 | - | - | Non-Qualified Stock Options (right to buy) | |
| Erin L. McSweeney | EVP & Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 502.73 per share. | 20 Feb 2025 | 1,232 | 9,432 (0%) | 0% | 502.7 | 619,361 | Common Stock |
| Erin L. McSweeney | EVP & Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 467.53 per share. | 20 Feb 2025 | 215 | 11,180 (0%) | 0% | 467.5 | 100,520 | Common Stock |
| Erin L. McSweeney | EVP & Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 467.60 per share. | 20 Feb 2025 | 206 | 11,396 (0%) | 0% | 467.6 | 96,326 | Common Stock |
| Erin L. McSweeney | EVP & Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 466.58 per share. | 20 Feb 2025 | 318 | 11,602 (0%) | 0% | 466.6 | 148,374 | Common Stock |
| Erin L. McSweeney | EVP & Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 2,488 | 11,920 (0%) | 0% | 0 | Common Stock | |
| Erin L. McSweeney | EVP & Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 3,673 | 10,665 (0%) | 0% | 0 | Common Stock | |
| Erin L. McSweeney | EVP & Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 10,553 | 10,553 | - | - | Non-Qualified Stock Options (right to buy) | |
| Thomas E. Roos | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 1,369 | 30,180 (0%) | 0% | 0 | Common Stock | |
| Thomas E. Roos | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 467.29 per share. | 20 Feb 2025 | 397 | 29,782 (0%) | 0% | 467.3 | 185,515 | Common Stock |
| Thomas E. Roos | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 468.45 per share. | 20 Feb 2025 | 148 | 29,634 (0%) | 0% | 468.4 | 69,330 | Common Stock |
| Thomas E. Roos | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 467.92 per share. | 20 Feb 2025 | 149 | 29,484 (0%) | 0% | 467.9 | 69,720 | Common Stock |
| Thomas E. Roos | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 5,804 | 5,804 | - | - | Non-Qualified Stock Options (right to buy) | |
| John F. Rex | President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 31,657 | 31,657 | - | - | Non-Qualified Stock Options (right to buy) | |
| John F. Rex | President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 11,763 | 187,448 (0%) | 0% | 0 | Common Stock | |
| John F. Rex | President & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 502.45 per share. | 20 Feb 2025 | 5,787 | 181,661 (0%) | 0% | 502.5 | 2,907,704 | Common Stock |
| John F. Rex | President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 7,464 | 189,125 (0%) | 0% | 0 | Common Stock | |
| John F. Rex | President & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 466.52 per share. | 20 Feb 2025 | 1,078 | 188,047 (0%) | 0% | 466.5 | 502,909 | Common Stock |
| John F. Rex | President & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 466.51 per share. | 20 Feb 2025 | 823 | 187,223 (0%) | 0% | 466.5 | 383,941 | Common Stock |
| John F. Rex | President & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 467.02 per share. | 20 Feb 2025 | 678 | 186,545 (0%) | 0% | 467.0 | 316,639 | Common Stock |
| Christopher Zaetta | EVP & Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 468.48 per share. | 20 Feb 2025 | 212 | 10,497 (0%) | 0% | 468.5 | 99,317 | Common Stock |
| Christopher Zaetta | EVP & Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 469.53 per share. | 20 Feb 2025 | 108 | 10,389 (0%) | 0% | 469.5 | 50,709 | Common Stock |
| Christopher Zaetta | EVP & Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 470.23 per share. | 20 Feb 2025 | 109 | 10,279 (0%) | 0% | 470.2 | 51,255 | Common Stock |
| Christopher Zaetta | EVP & Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 14,773 | 14,773 | - | - | Non-Qualified Stock Options (right to buy) | |
| Christopher Zaetta | EVP & Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 3,484 | 10,710 (0%) | 0% | 0 | Common Stock | |
| Timothy John Noel | Chief Executive Officer, UHC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 466.74 per share. | 20 Feb 2025 | 230 | 9,570 (0%) | 0% | 466.7 | 107,351 | Common Stock |
| Timothy John Noel | Chief Executive Officer, UHC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 3,981 | 9,800 (0%) | 0% | 0 | Common Stock | |
| Timothy John Noel | Chief Executive Officer, UHC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 502.62 per share. | 20 Feb 2025 | 882 | 5,819 (0%) | 0% | 502.6 | 443,315 | Common Stock |
| Timothy John Noel | Chief Executive Officer, UHC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 2,467 | 6,701 (0%) | 0% | 0 | Common Stock | |
| Timothy John Noel | Chief Executive Officer, UHC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 16,884 | 16,884 | - | - | Non-Qualified Stock Options (right to buy) | |
| Timothy John Noel | Chief Executive Officer, UHC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 468.41 per share. | 20 Feb 2025 | 221 | 9,168 (0%) | 0% | 468.4 | 103,518 | Common Stock |
| Timothy John Noel | Chief Executive Officer, UHC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 468.02 per share. | 20 Feb 2025 | 179 | 9,390 (0%) | 0% | 468.0 | 83,775 | Common Stock |
| Heather R. Cianfrocco | Chief Executive Officer, Optum | Payment of exercise price or tax liability using portion of securities received from the company at price $ 502.61 per share. | 20 Feb 2025 | 1,698 | 19,413 (0%) | 0% | 502.6 | 853,439 | Common Stock |
| Heather R. Cianfrocco | Chief Executive Officer, Optum | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 4,365 | 21,112 (0%) | 0% | 0 | Common Stock | |
| Heather R. Cianfrocco | Chief Executive Officer, Optum | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 3,981 | 23,394 (0%) | 0% | 0 | Common Stock | |
| Heather R. Cianfrocco | Chief Executive Officer, Optum | Payment of exercise price or tax liability using portion of securities received from the company at price $ 467.64 per share. | 20 Feb 2025 | 263 | 23,131 (0%) | 0% | 467.6 | 122,989 | Common Stock |
| Heather R. Cianfrocco | Chief Executive Officer, Optum | Payment of exercise price or tax liability using portion of securities received from the company at price $ 466.63 per share. | 20 Feb 2025 | 342 | 22,789 (0%) | 0% | 466.6 | 159,587 | Common Stock |
| Heather R. Cianfrocco | Chief Executive Officer, Optum | Payment of exercise price or tax liability using portion of securities received from the company at price $ 467.40 per share. | 20 Feb 2025 | 396 | 22,392 (0%) | 0% | 467.4 | 185,090 | Common Stock |
| Heather R. Cianfrocco | Chief Executive Officer, Optum | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 16,884 | 16,884 | - | - | Non-Qualified Stock Options (right to buy) | |
| Andrew P. Witty | Director, CEO, UHG | Payment of exercise price or tax liability using portion of securities received from the company at price $ 523.82 per share. | 14 Feb 2025 | 1,066 | 96,219 (0%) | 0% | 523.8 | 558,392 | Common Stock |
| Erin L. McSweeney | EVP & Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 525.67 per share. | 14 Feb 2025 | 138 | 6,992 (0%) | 0% | 525.7 | 72,543 | Common Stock |
| Thomas E. Roos | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 523.91 per share. | 14 Feb 2025 | 300 | 28,811 (0%) | 0% | 523.9 | 157,174 | Common Stock |
| John F. Rex | President & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 523.60 per share. | 14 Feb 2025 | 799 | 175,685 (0%) | 0% | 523.6 | 418,354 | Common Stock |
| Christopher Zaetta | EVP & Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 525.76 per share. | 14 Feb 2025 | 176 | 7,226 (0%) | 0% | 525.8 | 92,534 | Common Stock |
| Timothy John Noel | Chief Executive Officer, UHC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 526.01 per share. | 14 Feb 2025 | 113 | 4,234 (0%) | 0% | 526.0 | 59,439 | Common Stock |
| Heather R. Cianfrocco | Chief Executive Officer, Optum | Payment of exercise price or tax liability using portion of securities received from the company at price $ 523.63 per share. | 14 Feb 2025 | 182 | 16,747 (0%) | 0% | 523.6 | 95,300 | Common Stock |
| John F. Rex | President & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2025 | 25,504 | 0 | - | - | Non-Qualified Stock Options (right to buy) | |
| John F. Rex | President & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 108.97 per share. | 07 Feb 2025 | 25,504 | 191,690 (0%) | 0% | 109.0 | 2,779,171 | Common Stock |
| John F. Rex | President & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 531.48 per share. | 07 Feb 2025 | 15,206 | 176,484 (0%) | 0% | 531.5 | 8,081,685 | Common Stock |
| Timothy Patrick Flynn | Director | Purchase of securities on an exchange or from another person at price $ 511.58 per share. | 17 Jan 2025 | 1,000 | 4,500 (0%) | 0% | 511.6 | 511,575 | Common Stock |
| Michele J. Hooper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 112 | 39,780 (0%) | 0% | 0 | Common Stock | |
| Paul R. Garcia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 62 | 2,296 (0%) | 0% | 0 | Common Stock | |
| Paul R. Garcia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 112 | 2,234 (0%) | 0% | 0 | Common Stock | |
| Stephen J. Hemsley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 283 | 906,788 (0%) | 0% | 0 | Common Stock | |
| Timothy Patrick Flynn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 186 | 8,905 (0%) | 0% | 0 | Common Stock | |
| Charles D. Baker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 174 | 799 (0%) | 0% | 0 | Common Stock | |
| John H. Noseworthy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 186 | 5,559 (0%) | 0% | 0 | Common Stock | |
| Valerie Montgomery Rice | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 186 | 6,052 (0%) | 0% | 0 | Common Stock | |
| Kristen L. Gil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 112 | 1,377 (0%) | 0% | 0 | Common Stock | |
| Kristen L. Gil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 62 | 1,439 (0%) | 0% | 0 | Common Stock | |
| F. William McNabb | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 190 | 13,443 (0%) | 0% | 0 | Common Stock | |
| Flynn Timothy Patrick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2024 | 38 | 8,719 (0%) | 0% | 0 | Common Stock | |
| Stephen Hemsley J. | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 17 Dec 2024 | 33,000 | 906,505 (0%) | 0% | 0 | Common Stock | |
| Hemsley J. Stephen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2024 | 31 | 939,505 (0%) | 0% | 0 | Common Stock | |
| Montgomery Rice Valerie | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2024 | 24 | 5,866 (0%) | 0% | 0 | Common Stock | |
| L. Kristen Gil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2024 | 4 | 1,265 (0%) | 0% | 0 | Common Stock | |
| Noseworthy John H. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2024 | 24 | 5,373 (0%) | 0% | 0 | Common Stock | |
| John F. Rex | President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2024 | 77 | 166,186 (0%) | 0% | 0 | Common Stock | |
| D. Baker Charles | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2024 | 3 | 625 (0%) | 0% | 0 | Common Stock | |
| Andrew Witty P. | Director, CEO, UHG | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2024 | 114 | 97,286 (0%) | 0% | 0 | Common Stock | |
| E. Roos Thomas | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2024 | 17 | 29,094 (0%) | 0% | 0 | Common Stock | |
| F. McNabb William | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2024 | 30 | 13,253 (0%) | 0% | 0 | Common Stock | |
| Erin L. McSweeney | EVP & Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2024 | 25 | 7,131 (0%) | 0% | 0 | Common Stock | |
| Michele Hooper J. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2024 | 157 | 39,668 (0%) | 0% | 0 | Common Stock | |
| R. Paul Garcia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2024 | 6 | 2,122 (0%) | 0% | 0 | Common Stock | |
| Zaetta Chris | EVP & Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2024 | 23 | 7,403 (0%) | 0% | 0 | Common Stock | |
| John F. Rex | President & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 607.00 per share. | 13 Nov 2024 | 314 | 166,109 (0%) | 0% | 607 | 190,598 | Common Stock |
| Stephen J. Hemsley | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 11 Nov 2024 | 8,000 | 939,474 (0%) | 0% | 0 | Common Stock | |
| Erin L. McSweeney | EVP & Chief People Officer | Sale of securities on an exchange or to another person at price $ 626.23 per share. | 11 Nov 2024 | 701 | 7,105 (0%) | 0% | 626.2 | 438,987 | Common Stock |
| Chris Zaetta | EVP & Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 567.99 per share. | 01 Nov 2024 | 685 | 7,380 (0%) | 0% | 568.0 | 389,073 | Common Stock |
| Michele J. Hooper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2024 | 97 | 39,511 (0%) | 0% | 0 | Common Stock | |
| Paul R. Garcia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2024 | 54 | 2,116 (0%) | 0% | 0 | Common Stock | |
| Paul R. Garcia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2024 | 97 | 2,062 (0%) | 0% | 0 | Common Stock | |
| Stephen J. Hemsley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2024 | 245 | 947,474 (0%) | 0% | 0 | Common Stock | |
| Timothy Patrick Flynn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2024 | 161 | 10,181 (0%) | 0% | 0 | Common Stock | |
| Charles D. Baker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2024 | 151 | 622 (0%) | 0% | 0 | Common Stock | |
| John H. Noseworthy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2024 | 161 | 5,349 (0%) | 0% | 0 | Common Stock | |
| Valerie Montgomery Rice | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2024 | 161 | 5,842 (0%) | 0% | 0 | Common Stock | |
| Kristen L. Gil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2024 | 54 | 1,261 (0%) | 0% | 0 | Common Stock | |
| Kristen L. Gil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2024 | 97 | 1,207 (0%) | 0% | 0 | Common Stock | |
| F. William McNabb | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2024 | 164 | 13,223 (0%) | 0% | 0 | Common Stock | |
| Michele J. Hooper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Sep 2024 | 132 | 39,414 (0%) | 0% | 0 | Common Stock | |
| Paul R. Garcia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Sep 2024 | 5 | 1,965 (0%) | 0% | 0 | Common Stock | |
| Stephen J. Hemsley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Sep 2024 | 25 | 947,229 (0%) | 0% | 0 | Common Stock | |
| Andrew P. Witty | Director, CEO, UHG | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Sep 2024 | 95 | 97,172 (0%) | 0% | 0 | Common Stock | |
| Timothy Patrick Flynn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Sep 2024 | 31 | 10,020 (0%) | 0% | 0 | Common Stock | |
| Charles D. Baker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Sep 2024 | 2 | 471 (0%) | 0% | 0 | Common Stock | |
| Erin L. McSweeney | EVP & Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Sep 2024 | 21 | 7,806 (0%) | 0% | 0 | Common Stock | |
| Thomas E. Roos | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Sep 2024 | 14 | 29,077 (0%) | 0% | 0 | Common Stock | |
| John F. Rex | President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Sep 2024 | 66 | 166,423 (0%) | 0% | 0 | Common Stock | |
| John H. Noseworthy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Sep 2024 | 19 | 5,188 (0%) | 0% | 0 | Common Stock | |
| Valerie Montgomery Rice | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Sep 2024 | 20 | 5,681 (0%) | 0% | 0 | Common Stock | |
| Kristen L. Gil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Sep 2024 | 3 | 1,110 (0%) | 0% | 0 | Common Stock | |
| F. William McNabb | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Sep 2024 | 25 | 13,059 (0%) | 0% | 0 | Common Stock | |
| Brian R. Thompson | CEO, UnitedHealthcare | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Sep 2024 | 38 | 32,674 (0%) | 0% | 0 | Common Stock | |
| Chris Zaetta | EVP & Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Sep 2024 | 24 | 8,065 (0%) | 0% | 0 | Common Stock | |
| Stephen J. Hemsley | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 16 Sep 2024 | 5,176 | 0 (0%) | 0% | 0 | Common Stock | |
| Stephen J. Hemsley | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 16 Sep 2024 | 4,192 | 0 (0%) | 0% | 0 | Common Stock | |
| Stephen J. Hemsley | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Sep 2024 | 35,000 | 818,356 (0%) | 0% | 0 | Common Stock | |
| Stephen J. Hemsley | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Sep 2024 | 9,000 | 809,356 (0%) | 0% | 0 | Common Stock | |
| Paul R. Garcia | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 18 Jul 2024 | 30 | 0 (0%) | 0% | 0 | Common Stock | |
| Erin L. McSweeney | EVP & Chief People Officer | Sale of securities on an exchange or to another person at price $ 579.03 per share. | 18 Jul 2024 | 1,500 | 7,784 (0%) | 0% | 579.0 | 868,538 | Common Stock |
| Thomas E. Roos | Chief Accounting Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 17 Jul 2024 | 439 | 29,062 (0%) | 0% | 0 | Common Stock | |
| Thomas E. Roos | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 569.88 per share. | 17 Jul 2024 | 2,851 | 29,501 (0%) | 0% | 569.9 | 1,624,734 | Common Stock |
| Michele J. Hooper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 114 | 39,282 (0%) | 0% | 0 | Common Stock | |
| Paul R. Garcia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 114 | 1,896 (0%) | 0% | 0 | Common Stock | |
| Paul R. Garcia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 64 | 1,960 (0%) | 0% | 0 | Common Stock | |
| Stephen J. Hemsley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 289 | 810,856 (0%) | 0% | 0 | Common Stock | |
| Timothy Patrick Flynn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 190 | 9,989 (0%) | 0% | 0 | Common Stock | |
| Charles D. Baker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 177 | 469 (0%) | 0% | 0 | Common Stock | |
| John H. Noseworthy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 190 | 5,169 (0%) | 0% | 0 | Common Stock | |
| Valerie Montgomery Rice | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 190 | 5,661 (0%) | 0% | 0 | Common Stock | |
| Kristen L. Gil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 64 | 1,107 (0%) | 0% | 0 | Common Stock | |
| Kristen L. Gil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 114 | 1,043 (0%) | 0% | 0 | Common Stock | |
| F. William McNabb | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 194 | 13,034 (0%) | 0% | 0 | Common Stock | |
| Michele J. Hooper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2024 | 155 | 39,168 (0%) | 0% | 0 | Common Stock | |
| Paul R. Garcia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2024 | 5 | 1,782 (0%) | 0% | 0 | Common Stock | |
| Stephen J. Hemsley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2024 | 28 | 810,567 (0%) | 0% | 0 | Common Stock | |
| Andrew P. Witty | Director, CEO, UHG | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2024 | 110 | 97,029 (0%) | 0% | 0 | Common Stock | |
| Timothy Patrick Flynn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2024 | 36 | 9,799 (0%) | 0% | 0 | Common Stock | |
| Charles D. Baker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2024 | 2 | 292 (0%) | 0% | 0 | Common Stock | |
| Erin L. McSweeney | EVP & Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2024 | 25 | 9,284 (0%) | 0% | 0 | Common Stock | |
| Thomas E. Roos | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2024 | 17 | 32,321 (0%) | 0% | 0 | Common Stock | |
| John F. Rex | President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2024 | 76 | 166,357 (0%) | 0% | 0 | Common Stock | |
| John H. Noseworthy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2024 | 22 | 4,979 (0%) | 0% | 0 | Common Stock | |
| Valerie Montgomery Rice | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2024 | 22 | 5,471 (0%) | 0% | 0 | Common Stock | |
| Kristen L. Gil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2024 | 3 | 929 (0%) | 0% | 0 | Common Stock | |
| F. William McNabb | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2024 | 28 | 12,840 (0%) | 0% | 0 | Common Stock | |
| Brian R. Thompson | CEO, UnitedHealthcare | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2024 | 44 | 32,636 (0%) | 0% | 0 | Common Stock | |
| Chris Zaetta | EVP & Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2024 | 28 | 8,040 (0%) | 0% | 0 | Common Stock | |
| Stephen J. Hemsley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 111.16 per share. | 14 Jun 2024 | 118,270 | 810,847 (0%) | 0% | 111.2 | 13,146,893 | Common Stock |
| Stephen J. Hemsley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 64,130 | 0 | - | - | Non-Qualified Stock Options (right to buy) | |
| Stephen J. Hemsley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 53,042 | 0 | - | - | Non-Qualified Stock Options (right to buy) | |
| Stephen J. Hemsley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 96,706 | 0 | - | - | Non-Qualified Stock Options (right to buy) | |
| Stephen J. Hemsley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 118,270 | 0 | - | - | Non-Qualified Stock Options (right to buy) | |
| Stephen J. Hemsley | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 496.66 per share. | 14 Jun 2024 | 47,716 | 810,539 (0%) | 0% | 496.7 | 23,698,629 | Common Stock |
| Stephen J. Hemsley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 262.98 per share. | 14 Jun 2024 | 64,130 | 858,255 (0%) | 0% | 263.0 | 16,864,907 | Common Stock |
| Stephen J. Hemsley | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 496.86 per share. | 14 Jun 2024 | 37,350 | 794,125 (0%) | 0% | 496.9 | 18,557,721 | Common Stock |
| Stephen J. Hemsley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 226.64 per share. | 14 Jun 2024 | 53,042 | 831,475 (0%) | 0% | 226.6 | 12,021,439 | Common Stock |
| Stephen J. Hemsley | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 496.69 per share. | 14 Jun 2024 | 61,078 | 778,433 (0%) | 0% | 496.7 | 30,336,832 | Common Stock |
| Stephen J. Hemsley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 160.31 per share. | 14 Jun 2024 | 96,706 | 839,511 (0%) | 0% | 160.3 | 15,502,939 | Common Stock |
| Stephen J. Hemsley | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 496.83 per share. | 14 Jun 2024 | 68,042 | 742,805 (0%) | 0% | 496.8 | 33,805,307 | Common Stock |
| Erin L. McSweeney | EVP & Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 491.10 per share. | 07 Jun 2024 | 128 | 9,259 (0%) | 0% | 491.1 | 62,861 | Common Stock |
| Brian R. Thompson | CEO, UnitedHealthcare | Payment of exercise price or tax liability using portion of securities received from the company at price $ 492.32 per share. | 07 Jun 2024 | 259 | 32,592 (0%) | 0% | 492.3 | 127,511 | Common Stock |
| Stephen J. Hemsley | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Jun 2024 | 7,850 | 692,577 (0%) | 0% | 0 | Common Stock | |
| John F. Rex | President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 302 | 166,281 (0%) | 0% | 0 | Common Stock | |
| John F. Rex | President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 1,125 | 1,125 | - | - | Non-Qualified Stock Options (right to buy) | |
| Michele J. Hooper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 115 | 39,013 (0%) | 0% | 0 | Common Stock | |
| Paul R. Garcia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 64 | 1,777 (0%) | 0% | 0 | Common Stock | |
| Paul R. Garcia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 115 | 1,713 (0%) | 0% | 0 | Common Stock | |
| Timothy Patrick Flynn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 192 | 9,763 (0%) | 0% | 0 | Common Stock | |
| Kristen L. Gil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 115 | 862 (0%) | 0% | 0 | Common Stock | |
| Kristen L. Gil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 64 | 926 (0%) | 0% | 0 | Common Stock | |
| F. William McNabb | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 196 | 12,812 (0%) | 0% | 0 | Common Stock | |
| Stephen J. Hemsley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 291 | 636,127 (0%) | 0% | 0 | Common Stock | |
| Charles D. Baker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 179 | 290 (0%) | 0% | 0 | Common Stock | |
| John H. Noseworthy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 192 | 4,957 (0%) | 0% | 0 | Common Stock | |
| Valerie Montgomery Rice | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 192 | 5,449 (0%) | 0% | 0 | Common Stock | |
| Paul R. Garcia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2024 | 4 | 3,744 (0%) | 0% | 0 | Common Stock | |
| Stephen J. Hemsley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2024 | 24 | 635,836 (0%) | 0% | 0 | Common Stock | |
| Andrew P. Witty | Director, CEO, UHG | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2024 | 99 | 96,919 (0%) | 0% | 0 | Common Stock | |
| Rupert Mark Boden Bondy | EVP & Chief Legal Officer | 19 Mar 2024 | 21 | 9,606 (0%) | 0% | 0 | Common Stock | ||
| Charles D. Baker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2024 | 1 | 111 (0%) | 0% | 0 | Common Stock | |
| Erin L. McSweeney | EVP & Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2024 | 23 | 9,387 (0%) | 0% | 0 | Common Stock | |
| Thomas E. Roos | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2024 | 15 | 32,304 (0%) | 0% | 0 | Common Stock | |
| John F. Rex | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2024 | 67 | 165,979 (0%) | 0% | 0 | Common Stock | |
| Valerie Montgomery Rice | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2024 | 19 | 5,257 (0%) | 0% | 0 | Common Stock | |
| Kristen L. Gil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2024 | 2 | 747 (0%) | 0% | 0 | Common Stock | |
| F. William McNabb | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2024 | 24 | 12,616 (0%) | 0% | 0 | Common Stock | |
| Brian R. Thompson | CEO, UnitedHealthcare | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2024 | 41 | 32,852 (0%) | 0% | 0 | Common Stock | |
| Michele J. Hooper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2024 | 135 | 38,898 (0%) | 0% | 0 | Common Stock | |
| Timothy Patrick Flynn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2024 | 31 | 9,571 (0%) | 0% | 0 | Common Stock | |
| Dirk C. McMahon | President & COO, UHG | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2024 | 41 | 70,546 (0%) | 0% | 0 | Common Stock | |
| John H. Noseworthy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2024 | 19 | 4,765 (0%) | 0% | 0 | Common Stock | |
| Erin L. McSweeney | EVP & Chief People Officer | Sale of securities on an exchange or to another person at price $ 483.48 per share. | 08 Mar 2024 | 1,236 | 9,363 (0%) | 0% | 483.5 | 597,582 | Common Stock |
| Bondy Mark Boden Rupert | EVP & Chief Legal Officer | 23 Feb 2024 | 278 | 9,585 (0%) | 0% | 528.4 | 146,897 | Common Stock | |
| Witty Andrew P. | Director, CEO, UHG | Payment of exercise price or tax liability using portion of securities received from the company at price $ 527.41 per share. | 22 Feb 2024 | 1,212 | 96,819 (0%) | 0% | 527.4 | 639,218 | Common Stock |
| John Rex F. | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 526.57 per share. | 22 Feb 2024 | 1,061 | 166,581 (0%) | 0% | 526.6 | 558,689 | Common Stock |
| Thompson R. Brian | CEO, UnitedHealthcare | Payment of exercise price or tax liability using portion of securities received from the company at price $ 526.87 per share. | 22 Feb 2024 | 475 | 33,280 (0%) | 0% | 526.9 | 250,265 | Common Stock |
| L. Erin McSweeney | EVP & Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 526.82 per share. | 22 Feb 2024 | 237 | 10,803 (0%) | 0% | 526.8 | 124,856 | Common Stock |
| C. McMahon Dirk | President & COO, UHG | Payment of exercise price or tax liability using portion of securities received from the company at price $ 526.82 per share. | 22 Feb 2024 | 979 | 71,123 (0%) | 0% | 526.8 | 515,759 | Common Stock |
| Thompson R. Brian | CEO, UnitedHealthcare | Payment of exercise price or tax liability using portion of securities received from the company at price $ 527.92 per share. | 22 Feb 2024 | 470 | 32,810 (0%) | 0% | 527.9 | 248,121 | Common Stock |
| Witty P. Andrew | Director, CEO, UHG | Payment of exercise price or tax liability using portion of securities received from the company at price $ 526.52 per share. | 22 Feb 2024 | 1,342 | 98,032 (0%) | 0% | 526.5 | 706,588 | Common Stock |
| Dirk C. McMahon | President & COO, UHG | Payment of exercise price or tax liability using portion of securities received from the company at price $ 527.44 per share. | 22 Feb 2024 | 618 | 70,505 (0%) | 0% | 527.4 | 325,960 | Common Stock |
| McSweeney L. Erin | EVP & Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 527.69 per share. | 22 Feb 2024 | 203 | 10,600 (0%) | 0% | 527.7 | 107,121 | Common Stock |
| Roos E. Thomas | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 527.75 per share. | 22 Feb 2024 | 390 | 33,292 (0%) | 0% | 527.7 | 205,821 | Common Stock |
| Roos E. Thomas | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 525.79 per share. | 22 Feb 2024 | 858 | 32,288 (0%) | 0% | 525.8 | 451,128 | Common Stock |
| Roos Thomas E. | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 530.10 per share. | 22 Feb 2024 | 145 | 33,146 (0%) | 0% | 530.1 | 76,865 | Common Stock |
| F. Rex John | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 527.79 per share. | 22 Feb 2024 | 669 | 165,911 (0%) | 0% | 527.8 | 353,092 | Common Stock |
| E. Roos Thomas | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2024 | 1,198 | 33,683 (0%) | 0% | 0 | Common Stock | |
| C. Dirk McMahon | President & COO, UHG | Payment of exercise price or tax liability using portion of securities received from the company at price $ 521.98 per share. | 21 Feb 2024 | 8,248 | 72,103 (0%) | 0% | 522.0 | 4,305,275 | Common Stock |
| Witty P. Andrew | Director, CEO, UHG | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2024 | 22,807 | 99,077 (0%) | 0% | 0 | Common Stock | |
| Bondy Rupert Mark Boden | EVP & Chief Legal Officer | 21 Feb 2024 | 2,156 | 9,863 (0%) | 0% | 0 | Common Stock | ||
| L. McSweeney Erin | EVP & Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2024 | 2,156 | 11,040 (0%) | 0% | 0 | Common Stock | |
| F. Rex John | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2024 | 26,154 | 26,154 | - | - | Non-Qualified Stock Options (right to buy) | |
| Brian Thompson R. | CEO, UnitedHealthcare | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2024 | 3,832 | 33,756 (0%) | 0% | 0 | Common Stock | |
| Mark Boden Bondy Rupert | EVP & Chief Legal Officer | 21 Feb 2024 | 8,173 | 8,173 | - | - | Non-Qualified Stock Options (right to buy) | ||
| R. Brian Thompson | CEO, UnitedHealthcare | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2024 | 8,330 | 33,722 (0%) | 0% | 0 | Common Stock | |
| Mark Boden Rupert Bondy | EVP & Chief Legal Officer | 21 Feb 2024 | 1,555 | 7,707 (0%) | 0% | 522.0 | 811,768 | Common Stock | |
| John F. Rex | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2024 | 18,088 | 169,645 (0%) | 0% | 0 | Common Stock | |
| Witty Andrew P. | Director, CEO, UHG | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2024 | 11,016 | 99,374 (0%) | 0% | 0 | Common Stock | |
| Thompson Brian R. | CEO, UnitedHealthcare | Payment of exercise price or tax liability using portion of securities received from the company at price $ 522.04 per share. | 21 Feb 2024 | 3,798 | 29,924 (0%) | 0% | 522.0 | 1,982,693 | Common Stock |
| F. John Rex | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2024 | 6,897 | 167,642 (0%) | 0% | 0 | Common Stock | |
| John F. Rex | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 521.99 per share. | 21 Feb 2024 | 8,899 | 160,745 (0%) | 0% | 522.0 | 4,645,166 | Common Stock |
| McMahon Dirk C. | President & COO, UHG | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2024 | 18,088 | 80,351 (0%) | 0% | 0 | Common Stock | |
| McSweeney L. Erin | EVP & Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2024 | 8,173 | 8,173 | - | - | Non-Qualified Stock Options (right to buy) | |
| Witty Andrew P. | Director, CEO, UHG | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2024 | 41,773 | 41,773 | - | - | Non-Qualified Stock Options (right to buy) | |
| E. Thomas Roos | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2024 | 4,541 | 4,541 | - | - | Non-Qualified Stock Options (right to buy) | |
| Rupert Mark Boden Bondy | EVP & Chief Legal Officer | 21 Feb 2024 | 3,240 | 9,263 (0%) | 0% | 0 | Common Stock | ||
| Thompson Brian R. | CEO, UnitedHealthcare | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2024 | 14,530 | 14,530 | - | - | Non-Qualified Stock Options (right to buy) | |
| P. Witty Andrew | Director, CEO, UHG | Payment of exercise price or tax liability using portion of securities received from the company at price $ 521.98 per share. | 21 Feb 2024 | 10,719 | 88,358 (0%) | 0% | 522.0 | 5,595,148 | Common Stock |
| Brian R. Thompson | CEO, UnitedHealthcare | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 6,535 | 0 | - | - | Non-Qualified Stock Options (right to buy) | |
| R. Thompson Brian | CEO, UnitedHealthcare | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 17,681 | 0 | - | - | Non-Qualified Stock Options (right to buy) | |
| R. Brian Thompson | CEO, UnitedHealthcare | Payment of exercise price or tax liability using portion of securities received from the company at price $ 521.07 per share. | 16 Feb 2024 | 4,074 | 34,088 (0%) | 0% | 521.1 | 2,122,839 | Common Stock |
| R. Thompson Brian | CEO, UnitedHealthcare | Payment of exercise price or tax liability using portion of securities received from the company at price $ 521.18 per share. | 16 Feb 2024 | 18,320 | 54,485 (0%) | 0% | 521.2 | 9,548,018 | Common Stock |
| Thompson Brian R. | CEO, UnitedHealthcare | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 23,747 | 0 | - | - | Non-Qualified Stock Options (right to buy) | |
| Thompson R. Brian | CEO, UnitedHealthcare | Exercise or conversion of derivative security received from the company (such as an option) at price $ 226.64 per share. | 16 Feb 2024 | 17,681 | 51,769 (0%) | 0% | 226.6 | 4,007,222 | Common Stock |
| Brian Thompson R. | CEO, UnitedHealthcare | Exercise or conversion of derivative security received from the company (such as an option) at price $ 160.31 per share. | 16 Feb 2024 | 6,535 | 38,162 (0%) | 0% | 160.3 | 1,047,626 | Common Stock |
| Thompson Brian R. | CEO, UnitedHealthcare | Sale of securities on an exchange or to another person at price $ 521.00 per share. | 16 Feb 2024 | 28,943 | 25,542 (0%) | 0% | 521 | 15,079,303 | Common Stock |
| Brian R. Thompson | CEO, UnitedHealthcare | Exercise or conversion of derivative security received from the company (such as an option) at price $ 243.20 per share. | 16 Feb 2024 | 13,008 | 58,292 (0%) | 0% | 243.2 | 3,163,546 | Common Stock |
| Thompson R. Brian | CEO, UnitedHealthcare | Payment of exercise price or tax liability using portion of securities received from the company at price $ 521.24 per share. | 16 Feb 2024 | 15,616 | 45,284 (0%) | 0% | 521.2 | 8,139,684 | Common Stock |
| Thompson R. Brian | CEO, UnitedHealthcare | Exercise or conversion of derivative security received from the company (such as an option) at price $ 262.98 per share. | 16 Feb 2024 | 21,377 | 60,900 (0%) | 0% | 263.0 | 5,621,723 | Common Stock |
| R. Brian Thompson | CEO, UnitedHealthcare | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 13,008 | 0 | - | - | Non-Qualified Stock Options (right to buy) | |
| R. Brian Thompson | CEO, UnitedHealthcare | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 21,377 | 0 | - | - | Non-Qualified Stock Options (right to buy) | |
| Thompson R. Brian | CEO, UnitedHealthcare | Payment of exercise price or tax liability using portion of securities received from the company at price $ 521.13 per share. | 16 Feb 2024 | 12,246 | 39,523 (0%) | 0% | 521.1 | 6,381,758 | Common Stock |
| Thompson Brian R. | CEO, UnitedHealthcare | Exercise or conversion of derivative security received from the company (such as an option) at price $ 302.20 per share. | 16 Feb 2024 | 23,747 | 72,805 (0%) | 0% | 302.2 | 7,176,343 | Common Stock |
| Brian R. Thompson | CEO, UnitedHealthcare | Payment of exercise price or tax liability using portion of securities received from the company at price $ 521.18 per share. | 16 Feb 2024 | 9,234 | 49,058 (0%) | 0% | 521.2 | 4,812,530 | Common Stock |
| Thomas E. Roos | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 517.56 per share. | 13 Feb 2024 | 409 | 32,780 (0%) | 0% | 517.6 | 211,683 | Common Stock |
| John F. Rex | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 516.88 per share. | 13 Feb 2024 | 924 | 152,343 (0%) | 0% | 516.9 | 477,593 | Common Stock |
| Thompson Brian R. | CEO, UnitedHealthcare | Payment of exercise price or tax liability using portion of securities received from the company at price $ 517.40 per share. | 13 Feb 2024 | 307 | 31,627 (0%) | 0% | 517.4 | 158,842 | Common Stock |
| Dirk McMahon C. | President & COO, UHG | Payment of exercise price or tax liability using portion of securities received from the company at price $ 517.60 per share. | 13 Feb 2024 | 562 | 62,989 (0%) | 0% | 517.6 | 290,894 | Common Stock |
| R. Thompson Brian | CEO, UnitedHealthcare | Payment of exercise price or tax liability using portion of securities received from the company at price $ 517.59 per share. | 13 Feb 2024 | 340 | 31,934 (0%) | 0% | 517.6 | 175,979 | Common Stock |
| Erin McSweeney L. | EVP & Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 517.17 per share. | 13 Feb 2024 | 136 | 8,884 (0%) | 0% | 517.2 | 70,335 | Common Stock |
| Rex F. John | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 517.25 per share. | 13 Feb 2024 | 786 | 151,557 (0%) | 0% | 517.2 | 406,555 | Common Stock |
| McMahon Dirk C. | President & COO, UHG | Payment of exercise price or tax liability using portion of securities received from the company at price $ 516.96 per share. | 13 Feb 2024 | 726 | 62,263 (0%) | 0% | 517.0 | 375,314 | Common Stock |
| E. Roos Thomas | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 518.38 per share. | 13 Feb 2024 | 294 | 32,485 (0%) | 0% | 518.4 | 152,404 | Common Stock |
| Andrew Witty P. | Director, CEO, UHG | Payment of exercise price or tax liability using portion of securities received from the company at price $ 517.20 per share. | 13 Feb 2024 | 1,101 | 77,285 (0%) | 0% | 517.2 | 569,439 | Common Stock |
| Witty Andrew P. | Director, CEO, UHG | Payment of exercise price or tax liability using portion of securities received from the company at price $ 517.30 per share. | 13 Feb 2024 | 1,049 | 76,235 (0%) | 0% | 517.3 | 542,643 | Common Stock |
| L. McSweeney Erin | EVP & Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 517.36 per share. | 13 Feb 2024 | 221 | 9,020 (0%) | 0% | 517.4 | 114,337 | Common Stock |
| Baker Charles D. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 110 | 110 (0%) | 0% | 0 | Common Stock | |
| Michele J. Hooper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 105 | 38,763 (0%) | 0% | 0 | Common Stock | |
| Flynn Timothy Patrick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 174 | 9,540 (0%) | 0% | 0 | Common Stock | |
| Garcia Paul R. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 105 | 3,682 (0%) | 0% | 0 | Common Stock | |
| R. Garcia Paul | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 58 | 3,740 (0%) | 0% | 0 | Common Stock | |
| John Noseworthy H. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 174 | 4,746 (0%) | 0% | 0 | Common Stock | |
| L. Kristen Gil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 58 | 745 (0%) | 0% | 0 | Common Stock | |
| J. Hemsley Stephen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 265 | 635,812 (0%) | 0% | 0 | Common Stock | |
| F. McNabb William | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 178 | 12,592 (0%) | 0% | 0 | Common Stock | |
| Gil L. Kristen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 105 | 687 (0%) | 0% | 0 | Common Stock | |
| Valerie Montgomery Rice | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 174 | 5,238 (0%) | 0% | 0 | Common Stock | |
| Garcia Paul R. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2023 | 3 | 3,577 (0%) | 0% | 0 | Common Stock | |
| McNabb F. William | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2023 | 21 | 12,414 (0%) | 0% | 0 | Common Stock | |
| H. John Noseworthy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2023 | 16 | 4,572 (0%) | 0% | 0 | Common Stock | |
| Rupert Bondy Mark Boden | EVP & Chief Legal Officer | 12 Dec 2023 | 14 | 6,023 (0%) | 0% | 0 | Common Stock | ||
| L. Kristen Gil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2023 | 2 | 582 (0%) | 0% | 0 | Common Stock | |
| Hooper J. Michele | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2023 | 122 | 38,658 (0%) | 0% | 0 | Common Stock | |
| J. Stephen Hemsley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2023 | 20 | 635,547 (0%) | 0% | 0 | Common Stock | |
| Timothy Flynn Patrick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2023 | 28 | 9,366 (0%) | 0% | 0 | Common Stock | |
| L. McSweeney Erin | EVP & Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2023 | 23 | 9,241 (0%) | 0% | 0 | Common Stock | |
| C. Dirk McMahon | President & COO, UHG | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2023 | 63 | 63,851 (0%) | 0% | 0 | Common Stock | |
| Andrew Witty P. | Director, CEO, UHG | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2023 | 86 | 78,387 (0%) | 0% | 0 | Common Stock | |
| R. Thompson Brian | CEO, UnitedHealthcare | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2023 | 38 | 32,275 (0%) | 0% | 0 | Common Stock | |
| John F. Rex | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2023 | 63 | 153,566 (0%) | 0% | 0 | Common Stock | |
| Valerie Montgomery Rice | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2023 | 17 | 5,064 (0%) | 0% | 0 | Common Stock | |
| Roos E. Thomas | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2023 | 18 | 33,172 (0%) | 0% | 0 | Common Stock | |
| Dirk C. McMahon | President & COO, UHG | Payment of exercise price or tax liability using portion of securities received from the company at price $ 550.30 per share. | 12 Dec 2023 | 298 | 63,552 (0%) | 0% | 550.3 | 163,990 | Common Stock |
| F. John Rex | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 550.30 per share. | 12 Dec 2023 | 298 | 153,267 (0%) | 0% | 550.3 | 163,990 | Common Stock |
| Stephen Hemsley J. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Dec 2023 | 66,081 | 0 | - | - | Non-Qualified Stock Options (right to buy) | |
| Stephen J. Hemsley | Director | Sale of securities on an exchange or to another person at price $ 550.39 per share. | 05 Dec 2023 | 66,081 | 635,527 (0%) | 0% | 550.4 | 36,370,196 | Common Stock |
| Stephen J. Hemsley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 108.97 per share. | 05 Dec 2023 | 66,081 | 701,608 (0%) | 0% | 109.0 | 7,200,847 | Common Stock |
| Stephen J. Hemsley | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 22 Nov 2023 | 18,500 | 635,527 (0%) | 0% | 0 | Common Stock | |
| Stephen J. Hemsley | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 16 Nov 2023 | 22,259 | 654,027 (0%) | 0% | 0 | Common Stock | |
| Andrew P. Witty | Director, CEO, UHG | Payment of exercise price or tax liability using portion of securities received from the company at price $ 534.88 per share. | 06 Nov 2023 | 372 | 78,300 (0%) | 0% | 534.9 | 198,977 | Common Stock |
| Stephen J. Hemsley | Director | Sale of securities on an exchange or to another person at price $ 540.58 per share. | 17 Oct 2023 | 121,515 | 521,817 (0%) | 0% | 540.6 | 65,688,591 | Common Stock |
| Stephen J. Hemsley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 70.24 per share. | 17 Oct 2023 | 83,918 | 605,735 (0%) | 0% | 70.2 | 5,894,400 | Common Stock |
| Stephen J. Hemsley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 108.97 per share. | 17 Oct 2023 | 37,597 | 643,332 (0%) | 0% | 109.0 | 4,096,945 | Common Stock |
| Stephen J. Hemsley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Oct 2023 | 37,597 | 66,081 | - | - | Non-Qualified Stock Options (right to buy) | |
| Stephen J. Hemsley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Oct 2023 | 83,918 | 0 | - | - | Non-Qualified Stock Options (right to buy) | |
| Erin L. McSweeney | EVP Chief People Officer | Sale of securities on an exchange or to another person at price $ 544.28 per share. | 16 Oct 2023 | 4,498 | 9,218 (0%) | 0% | 544.3 | 2,448,192 | Common Stock |
| Erin L. McSweeney | EVP Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Oct 2023 | 4,498 | 4,750 | - | - | Non-Qualified Stock Options (right to buy) | |
| Erin L. McSweeney | EVP Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 302.20 per share. | 16 Oct 2023 | 4,498 | 13,716 (0%) | 0% | 302.2 | 1,359,296 | Common Stock |
| Michele J. Hooper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2023 | 110 | 38,536 (0%) | 0% | 0 | Common Stock | |
| Paul R. Garcia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2023 | 110 | 3,513 (0%) | 0% | 0 | Common Stock | |
| Paul R. Garcia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2023 | 61 | 3,574 (0%) | 0% | 0 | Common Stock | |
| Stephen J. Hemsley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2023 | 277 | 521,817 (0%) | 0% | 0 | Common Stock | |
| Timothy Patrick Flynn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2023 | 183 | 9,338 (0%) | 0% | 0 | Common Stock | |
| John H. Noseworthy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2023 | 183 | 4,556 (0%) | 0% | 0 | Common Stock | |
| Valerie Montgomery Rice | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2023 | 49 | 5,047 (0%) | 0% | 0 | Common Stock | |
| Valerie Montgomery Rice | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2023 | 134 | 4,998 (0%) | 0% | 0 | Common Stock | |
| Kristen L. Gil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2023 | 61 | 580 (0%) | 0% | 0 | Common Stock | |
| Kristen L. Gil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2023 | 110 | 519 (0%) | 0% | 0 | Common Stock | |
| F. William McNabb | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2023 | 186 | 12,393 (0%) | 0% | 0 | Common Stock | |
| Michele J. Hooper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Sep 2023 | 137 | 38,426 (0%) | 0% | 0 | Common Stock | |
| Paul R. Garcia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Sep 2023 | 3 | 3,403 (0%) | 0% | 0 | Common Stock | |
| Stephen J. Hemsley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Sep 2023 | 22 | 521,540 (0%) | 0% | 0 | Common Stock | |
| Andrew P. Witty | Director, CEO, UHG | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Sep 2023 | 100 | 78,673 (0%) | 0% | 0 | Common Stock | |
| Rupert Mark Boden Bondy | EVP & Chief Legal Officer | 19 Sep 2023 | 15 | 6,009 (0%) | 0% | 0 | Common Stock | ||
| Timothy Patrick Flynn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Sep 2023 | 30 | 9,155 (0%) | 0% | 0 | Common Stock | |
| Dirk C. McMahon | Pres. & COO, UHG | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Sep 2023 | 71 | 63,787 (0%) | 0% | 0 | Common Stock | |
| Dirk C. McMahon | Pres. & COO, UHG | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Sep 2023 | 71 | 63,787 (0%) | 0% | 0 | Common Stock | |
| Erin L. McSweeney | EVP Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Sep 2023 | 26 | 9,218 (0%) | 0% | 0 | Common Stock | |
| Thomas E. Roos | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Sep 2023 | 20 | 33,154 (0%) | 0% | 0 | Common Stock | |
| John F. Rex | EVP Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Sep 2023 | 71 | 153,502 (0%) | 0% | 0 | Common Stock | |
| John H. Noseworthy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Sep 2023 | 18 | 4,373 (0%) | 0% | 0 | Common Stock | |
| Valerie Montgomery Rice | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Sep 2023 | 18 | 4,864 (0%) | 0% | 0 | Common Stock | |
| Kristen L. Gil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Sep 2023 | 2 | 409 (0%) | 0% | 0 | Common Stock | |
| F. William McNabb | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Sep 2023 | 23 | 12,207 (0%) | 0% | 0 | Common Stock | |
| Brian R. Thompson | CEO, UnitedHealthcare | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Sep 2023 | 43 | 32,236 (0%) | 0% | 0 | Common Stock | |
| Thomas E. Roos | Chief Accounting Officer | Sale or transfer of securities back to the company at price $ 492.28 per share. | 29 Aug 2023 | 815 | 33,133 (0%) | 0% | 492.3 | 401,210 | Common Stock |
| Thomas E. Roos | Chief Accounting Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 29 Aug 2023 | 406 | 33,948 (0%) | 0% | 0 | Common Stock | |
| Stephen J. Hemsley | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Aug 2023 | 54,904 | 0 (0%) | 0% | 0 | Common Stock | |
| Brian R. Thompson | CEO, UnitedHealthcare | Payment of exercise price or tax liability using portion of securities received from the company at price $ 509.17 per share. | 11 Aug 2023 | 248 | 32,192 (0%) | 0% | 509.2 | 126,273 | Common Stock |
| Stephen J. Hemsley | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Jul 2023 | 60,732 | 0 (0%) | 0% | 0 | Common Stock | |
| Andrew P. Witty | Director, CEO, UHG | Sale of securities on an exchange or to another person at price $ 506.19 per share. | 19 Jul 2023 | 4,000 | 78,573 (0%) | 0% | 506.2 | 2,024,760 | Common Stock |
| Michele J. Hooper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2023 | 118 | 38,289 (0%) | 0% | 0 | Common Stock | |
| Paul R. Garcia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2023 | 118 | 3,334 (0%) | 0% | 0 | Common Stock | |
| Paul R. Garcia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2023 | 66 | 3,400 (0%) | 0% | 0 | Common Stock | |
| Stephen J. Hemsley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2023 | 299 | 320,444 (0%) | 0% | 0 | Common Stock | |
| Timothy Patrick Flynn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2023 | 197 | 9,125 (0%) | 0% | 0 | Common Stock | |
| John H. Noseworthy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2023 | 197 | 4,355 (0%) | 0% | 0 | Common Stock | |
| Valerie Montgomery Rice | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2023 | 118 | 4,767 (0%) | 0% | 0 | Common Stock | |
| Valerie Montgomery Rice | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2023 | 79 | 4,846 (0%) | 0% | 0 | Common Stock | |
| Kristen L. Gil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2023 | 66 | 407 (0%) | 0% | 0 | Common Stock | |
| Kristen L. Gil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2023 | 118 | 341 (0%) | 0% | 0 | Common Stock | |
| F. William McNabb | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2023 | 201 | 12,184 (0%) | 0% | 0 | Common Stock | |
| Michele J. Hooper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2023 | 136 | 38,171 (0%) | 0% | 0 | Common Stock | |
| Paul R. Garcia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2023 | 3 | 3,216 (0%) | 0% | 0 | Common Stock | |
| Stephen J. Hemsley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2023 | 21 | 320,145 (0%) | 0% | 0 | Common Stock | |
| Andrew P. Witty | Director, CEO, UHG | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2023 | 99 | 82,526 (0%) | 0% | 0 | Common Stock | |
| Rupert Mark Boden Bondy | EVP & Chief Legal Officer | 27 Jun 2023 | 15 | 5,993 (0%) | 0% | 0 | Common Stock | ||
| Timothy Patrick Flynn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2023 | 29 | 8,928 (0%) | 0% | 0 | Common Stock | |
| Dirk C. McMahon | Pres. & COO, UHG | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2023 | 71 | 63,669 (0%) | 0% | 0 | Common Stock | |
| Erin L. McSweeney | EVP Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2023 | 26 | 9,191 (0%) | 0% | 0 | Common Stock | |
| Thomas E. Roos | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2023 | 20 | 34,323 (0%) | 0% | 0 | Common Stock | |
| John F. Rex | EVP Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2023 | 71 | 153,431 (0%) | 0% | 0 | Common Stock | |
| John H. Noseworthy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2023 | 17 | 4,158 (0%) | 0% | 0 | Common Stock | |
| Valerie Montgomery Rice | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2023 | 17 | 4,649 (0%) | 0% | 0 | Common Stock | |
| Kristen L. Gil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2023 | 1 | 223 (0%) | 0% | 0 | Common Stock | |
| F. William McNabb | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2023 | 22 | 11,983 (0%) | 0% | 0 | Common Stock | |
| Brian R. Thompson | CEO, UnitedHealthcare | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2023 | 45 | 32,441 (0%) | 0% | 0 | Common Stock | |
| Erin L. McSweeney | EVP Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 485.18 per share. | 07 Jun 2023 | 127 | 9,165 (0%) | 0% | 485.2 | 61,618 | Common Stock |
| Brian R. Thompson | CEO, UnitedHealthcare | Payment of exercise price or tax liability using portion of securities received from the company at price $ 483.99 per share. | 07 Jun 2023 | 255 | 32,395 (0%) | 0% | 484.0 | 123,417 | Common Stock |
| Rupert Mark Boden Bondy | EVP & Chief Legal Officer | 06 Jun 2023 | 279 | 5,977 (0%) | 0% | 487.7 | 136,078 | Common Stock | |
| Andrew P. Witty | Director, CEO, UHG | Payment of exercise price or tax liability using portion of securities received from the company at price $ 498.22 per share. | 05 Jun 2023 | 4,137 | 82,426 (0%) | 0% | 498.2 | 2,061,146 | Common Stock |
| Andrew P. Witty | Director, CEO, UHG | Sale of securities on an exchange or to another person at price $ 487.49 per share. | 27 Apr 2023 | 6,160 | 86,563 (0%) | 0% | 487.5 | 3,002,949 | Common Stock |
| Erin L. McSweeney | EVP Chief People Officer | Sale of securities on an exchange or to another person at price $ 494.80 per share. | 21 Apr 2023 | 761 | 9,293 (0%) | 0% | 494.8 | 376,543 | Common Stock |
| Erin L. McSweeney | EVP Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 486.60 per share. | 21 Apr 2023 | 4,621 | 10,054 (0%) | 0% | 486.6 | 2,248,579 | Common Stock |
| Erin L. McSweeney | EVP Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 302.20 per share. | 21 Apr 2023 | 6,000 | 14,675 (0%) | 0% | 302.2 | 1,813,200 | Common Stock |
| Erin L. McSweeney | EVP Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Apr 2023 | 6,000 | 9,248 | - | - | Non-Qualified Stock Options (right to buy) | |
| Erin L. McSweeney | EVP Chief People Officer | Sale of securities on an exchange or to another person at price $ 488.46 per share. | 21 Apr 2023 | 1,684 | 8,675 (0%) | 0% | 488.5 | 822,562 | Common Stock |
| Erin L. McSweeney | EVP Chief People Officer | Sale of securities on an exchange or to another person at price $ 484.58 per share. | 21 Apr 2023 | 1,008 | 10,359 (0%) | 0% | 484.6 | 488,457 | Common Stock |
| Erin L. McSweeney | EVP Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 262.98 per share. | 19 Apr 2023 | 5,345 | 15,207 (0%) | 0% | 263.0 | 1,405,628 | Common Stock |
| Erin L. McSweeney | EVP Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Apr 2023 | 5,345 | 5,345 | - | - | Non-Qualified Stock Options (right to buy) | |
| Erin L. McSweeney | EVP Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 491.13 per share. | 19 Apr 2023 | 3,840 | 11,367 (0%) | 0% | 491.1 | 1,885,939 | Common Stock |
| Michele J. Hooper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2023 | 114 | 38,035 (0%) | 0% | 0 | Common Stock | |
| Paul R. Garcia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2023 | 64 | 3,213 (0%) | 0% | 0 | Common Stock | |
| Paul R. Garcia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2023 | 114 | 3,149 (0%) | 0% | 0 | Common Stock | |
| Stephen J. Hemsley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2023 | 289 | 412,857 (0%) | 0% | 0 | Common Stock | |
| Timothy Patrick Flynn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2023 | 190 | 8,899 (0%) | 0% | 0 | Common Stock | |
| John H. Noseworthy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2023 | 190 | 4,141 (0%) | 0% | 0 | Common Stock | |
| Valerie Montgomery Rice | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2023 | 114 | 4,556 (0%) | 0% | 0 | Common Stock | |
| Valerie Montgomery Rice | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2023 | 76 | 4,632 (0%) | 0% | 0 | Common Stock | |
| Kristen L. Gil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2023 | 64 | 222 (0%) | 0% | 0 | Common Stock | |
| Kristen L. Gil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2023 | 114 | 158 (0%) | 0% | 0 | Common Stock | |
| F. William McNabb | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2023 | 194 | 11,961 (0%) | 0% | 0 | Common Stock | |
| Michele J. Hooper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2023 | 119 | 37,921 (0%) | 0% | 0 | Common Stock | |
| Paul R. Garcia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2023 | 2 | 3,035 (0%) | 0% | 0 | Common Stock | |
| Stephen J. Hemsley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2023 | 17 | 412,568 (0%) | 0% | 0 | Common Stock | |
| Andrew P. Witty | Director, CEO, UHG | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2023 | 82 | 92,723 (0%) | 0% | 0 | Common Stock | |
| Rupert Mark Boden Bondy | EVP & Chief Legal Officer | 21 Mar 2023 | 15 | 6,256 (0%) | 0% | 0 | Common Stock | ||
| Timothy Patrick Flynn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2023 | 25 | 8,709 (0%) | 0% | 0 | Common Stock | |
| Dirk C. McMahon | Pres. & COO, UHG & CEO, UHC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2023 | 62 | 63,598 (0%) | 0% | 0 | Common Stock | |
| Erin L. McSweeney | EVP Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2023 | 24 | 9,862 (0%) | 0% | 0 | Common Stock | |
| Thomas E. Roos | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2023 | 18 | 34,302 (0%) | 0% | 0 | Common Stock | |
| John F. Rex | EVP Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2023 | 62 | 153,360 (0%) | 0% | 0 | Common Stock | |
| John H. Noseworthy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2023 | 14 | 3,951 (0%) | 0% | 0 | Common Stock | |
| Valerie Montgomery Rice | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2023 | 15 | 4,442 (0%) | 0% | 0 | Common Stock | |
| Kristen L. Gil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2023 | 1 | 44 (0%) | 0% | 0 | Common Stock | |
| F. William McNabb | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2023 | 19 | 11,767 (0%) | 0% | 0 | Common Stock | |
| Brian R. Thompson | CEO, UnitedHealthcare | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2023 | 42 | 32,651 (0%) | 0% | 0 | Common Stock | |
| Stephen J. Hemsley | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 484.37 per share. | 24 Feb 2023 | 999 | 412,551 (0%) | 0% | 484.4 | 483,887 | Common Stock |
| Andrew P. Witty | Director, CEO, UHG | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 37,206 | 37,206 | - | - | Non-Qualified Stock Options (right to buy) | |
| Andrew P. Witty | Director, CEO, UHG | Payment of exercise price or tax liability using portion of securities received from the company at price $ 491.71 per share. | 23 Feb 2023 | 9,994 | 83,627 (0%) | 0% | 491.7 | 4,914,198 | Common Stock |
| Andrew P. Witty | Director, CEO, UHG | Grant, award, or other acquisition of securities at price $ 491.69 per share. | 23 Feb 2023 | 10,170 | 93,797 (0%) | 0% | 491.7 | 5,000,487 | Common Stock |
| Andrew P. Witty | Director, CEO, UHG | Payment of exercise price or tax liability using portion of securities received from the company at price $ 484.33 per share. | 23 Feb 2023 | 1,156 | 92,641 (0%) | 0% | 484.3 | 559,884 | Common Stock |
| Andrew P. Witty | Director, CEO, UHG | Grant, award, or other acquisition of securities at price $ 491.69 per share. | 23 Feb 2023 | 20,714 | 93,621 (0%) | 0% | 491.7 | 10,184,867 | Common Stock |
| Rupert Mark Boden Bondy | EVP & Chief Legal Officer | 23 Feb 2023 | 8,372 | 8,372 | - | - | Non-Qualified Stock Options (right to buy) | ||
| Rupert Mark Boden Bondy | EVP & Chief Legal Officer | 23 Feb 2023 | 2,289 | 6,240 (0%) | 0% | 491.7 | 1,125,478 | Common Stock | |
| Rupert Mark Boden Bondy | EVP & Chief Legal Officer | 23 Feb 2023 | 1,351 | 3,951 (0%) | 0% | 491.7 | 664,300 | Common Stock | |
| Rupert Mark Boden Bondy | EVP & Chief Legal Officer | 23 Feb 2023 | 2,985 | 5,302 (0%) | 0% | 491.7 | 1,467,695 | Common Stock | |
| Dirk C. McMahon | Pres. & COO, UHG & CEO, UHC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 24,928 | 24,928 | - | - | Non-Qualified Stock Options (right to buy) | |
| Dirk C. McMahon | Pres. & COO, UHG & CEO, UHC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 484.53 per share. | 23 Feb 2023 | 600 | 63,535 (0%) | 0% | 484.5 | 290,717 | Common Stock |
| Dirk C. McMahon | Pres. & COO, UHG & CEO, UHC | Grant, award, or other acquisition of securities at price $ 491.69 per share. | 23 Feb 2023 | 6,814 | 64,135 (0%) | 0% | 491.7 | 3,350,376 | Common Stock |
| Dirk C. McMahon | Pres. & COO, UHG & CEO, UHC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 491.74 per share. | 23 Feb 2023 | 7,944 | 57,321 (0%) | 0% | 491.7 | 3,906,422 | Common Stock |
| Dirk C. McMahon | Pres. & COO, UHG & CEO, UHC | Grant, award, or other acquisition of securities at price $ 491.69 per share. | 23 Feb 2023 | 17,423 | 65,266 (0%) | 0% | 491.7 | 8,566,715 | Common Stock |
| Erin L. McSweeney | EVP Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 7,442 | 7,442 | - | - | Non-Qualified Stock Options (right to buy) | |
| Erin L. McSweeney | EVP Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 484.41 per share. | 23 Feb 2023 | 397 | 9,838 (0%) | 0% | 484.4 | 192,310 | Common Stock |
| Erin L. McSweeney | EVP Chief People Officer | Grant, award, or other acquisition of securities at price $ 491.69 per share. | 23 Feb 2023 | 2,034 | 10,235 (0%) | 0% | 491.7 | 1,000,097 | Common Stock |
| Thomas E. Roos | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 484.71 per share. | 23 Feb 2023 | 422 | 34,284 (0%) | 0% | 484.7 | 204,546 | Common Stock |
| Thomas E. Roos | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 491.69 per share. | 23 Feb 2023 | 1,170 | 34,706 (0%) | 0% | 491.7 | 575,277 | Common Stock |
| Thomas E. Roos | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 4,279 | 4,279 | - | - | Non-Qualified Stock Option (right to buy) | |
| John F. Rex | EVP Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 491.69 per share. | 23 Feb 2023 | 17,423 | 155,847 (0%) | 0% | 491.7 | 8,566,715 | Common Stock |
| John F. Rex | EVP Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 491.70 per share. | 23 Feb 2023 | 8,572 | 147,275 (0%) | 0% | 491.7 | 4,214,824 | Common Stock |
| John F. Rex | EVP Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 491.69 per share. | 23 Feb 2023 | 6,814 | 154,089 (0%) | 0% | 491.7 | 3,350,376 | Common Stock |
| John F. Rex | EVP Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 484.60 per share. | 23 Feb 2023 | 791 | 153,297 (0%) | 0% | 484.6 | 383,321 | Common Stock |
| John F. Rex | EVP Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 24,928 | 24,928 | - | - | Non-Qualified Stock Options (right to buy) | |
| Brian R. Thompson | CEO, UnitedHealthcare | Grant, award, or other acquisition of securities at price $ 491.69 per share. | 23 Feb 2023 | 9,680 | 33,416 (0%) | 0% | 491.7 | 4,759,559 | Common Stock |
| Brian R. Thompson | CEO, UnitedHealthcare | Payment of exercise price or tax liability using portion of securities received from the company at price $ 491.70 per share. | 23 Feb 2023 | 4,414 | 29,001 (0%) | 0% | 491.7 | 2,170,359 | Common Stock |
| Brian R. Thompson | CEO, UnitedHealthcare | Grant, award, or other acquisition of securities at price $ 491.69 per share. | 23 Feb 2023 | 4,068 | 33,069 (0%) | 0% | 491.7 | 2,000,195 | Common Stock |
| Brian R. Thompson | CEO, UnitedHealthcare | Payment of exercise price or tax liability using portion of securities received from the company at price $ 484.47 per share. | 23 Feb 2023 | 460 | 32,609 (0%) | 0% | 484.5 | 222,855 | Common Stock |
| Brian R. Thompson | CEO, UnitedHealthcare | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 14,883 | 14,883 | - | - | Non-Qualified Stock Options (right to buy) | |
| Andrew P. Witty | Director, CEO, UHG | Payment of exercise price or tax liability using portion of securities received from the company at price $ 489.14 per share. | 22 Feb 2023 | 1,357 | 80,232 (0%) | 0% | 489.1 | 663,760 | Common Stock |
| Andrew P. Witty | Director, CEO, UHG | Grant, award, or other acquisition of securities at price $ 489.04 per share. | 22 Feb 2023 | 2,813 | 81,590 (0%) | 0% | 489.0 | 1,375,668 | Common Stock |
| Dirk C. McMahon | Pres. & COO, UHG & CEO, UHC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 489.06 per share. | 22 Feb 2023 | 965 | 53,385 (0%) | 0% | 489.1 | 471,945 | Common Stock |
| Dirk C. McMahon | Pres. & COO, UHG & CEO, UHC | Grant, award, or other acquisition of securities at price $ 488.89 per share. | 22 Feb 2023 | 2,232 | 54,351 (0%) | 0% | 488.9 | 1,091,202 | Common Stock |
| Erin L. McSweeney | EVP Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 489.27 per share. | 22 Feb 2023 | 213 | 10,381 (0%) | 0% | 489.3 | 104,215 | Common Stock |
| Erin L. McSweeney | EVP Chief People Officer | Grant, award, or other acquisition of securities at price $ 488.89 per share. | 22 Feb 2023 | 783 | 10,594 (0%) | 0% | 488.9 | 382,799 | Common Stock |
| Thomas E. Roos | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 489.19 per share. | 22 Feb 2023 | 385 | 35,691 (0%) | 0% | 489.2 | 188,338 | Common Stock |
| Thomas E. Roos | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 488.89 per share. | 22 Feb 2023 | 783 | 36,076 (0%) | 0% | 488.9 | 382,799 | Common Stock |
| John F. Rex | EVP Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 488.98 per share. | 22 Feb 2023 | 910 | 143,509 (0%) | 0% | 489.0 | 444,975 | Common Stock |
| John F. Rex | EVP Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 489.08 per share. | 22 Feb 2023 | 1,942 | 144,419 (0%) | 0% | 489.1 | 949,788 | Common Stock |
| Brian R. Thompson | CEO, UnitedHealthcare | Payment of exercise price or tax liability using portion of securities received from the company at price $ 489.15 per share. | 22 Feb 2023 | 467 | 26,777 (0%) | 0% | 489.2 | 228,434 | Common Stock |
| Brian R. Thompson | CEO, UnitedHealthcare | Grant, award, or other acquisition of securities at price $ 489.01 per share. | 22 Feb 2023 | 1,028 | 27,244 (0%) | 0% | 489.0 | 502,705 | Common Stock |
| Andrew P. Witty | Director, CEO, UHG | Payment of exercise price or tax liability using portion of securities received from the company at price $ 495.61 per share. | 13 Feb 2023 | 1,114 | 77,637 (0%) | 0% | 495.6 | 552,113 | Common Stock |
| Andrew P. Witty | Director, CEO, UHG | Payment of exercise price or tax liability using portion of securities received from the company at price $ 493.27 per share. | 13 Feb 2023 | 1,061 | 78,776 (0%) | 0% | 493.3 | 523,363 | Common Stock |
| Andrew P. Witty | Director, CEO, UHG | Grant, award, or other acquisition of securities at price $ 493.04 per share. | 13 Feb 2023 | 2,200 | 79,838 (0%) | 0% | 493.0 | 1,084,691 | Common Stock |
| Andrew P. Witty | Director, CEO, UHG | Grant, award, or other acquisition of securities at price $ 495.36 per share. | 13 Feb 2023 | 2,310 | 78,751 (0%) | 0% | 495.4 | 1,144,276 | Common Stock |
| Dirk C. McMahon | Pres. & COO, UHG & CEO, UHC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 493.62 per share. | 13 Feb 2023 | 579 | 52,119 (0%) | 0% | 493.6 | 285,808 | Common Stock |
| Dirk C. McMahon | Pres. & COO, UHG & CEO, UHC | Grant, award, or other acquisition of securities at price $ 492.99 per share. | 13 Feb 2023 | 1,367 | 52,698 (0%) | 0% | 493.0 | 673,914 | Common Stock |
| Dirk C. McMahon | Pres. & COO, UHG & CEO, UHC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 496.06 per share. | 13 Feb 2023 | 548 | 51,331 (0%) | 0% | 496.1 | 271,841 | Common Stock |
| Dirk C. McMahon | Pres. & COO, UHG & CEO, UHC | Grant, award, or other acquisition of securities at price $ 495.50 per share. | 13 Feb 2023 | 1,942 | 51,880 (0%) | 0% | 495.5 | 962,266 | Common Stock |
| Erin L. McSweeney | EVP Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 496.33 per share. | 13 Feb 2023 | 129 | 9,811 (0%) | 0% | 496.3 | 64,026 | Common Stock |
| Erin L. McSweeney | EVP Chief People Officer | Grant, award, or other acquisition of securities at price $ 493.32 per share. | 13 Feb 2023 | 533 | 9,941 (0%) | 0% | 493.3 | 262,940 | Common Stock |
| Erin L. McSweeney | EVP Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 496.91 per share. | 13 Feb 2023 | 216 | 9,407 (0%) | 0% | 496.9 | 107,333 | Common Stock |
| Erin L. McSweeney | EVP Chief People Officer | Grant, award, or other acquisition of securities at price $ 495.50 per share. | 13 Feb 2023 | 863 | 9,624 (0%) | 0% | 495.5 | 427,616 | Common Stock |
| Thomas E. Roos | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 494.45 per share. | 13 Feb 2023 | 281 | 35,293 (0%) | 0% | 494.4 | 138,940 | Common Stock |
| Thomas E. Roos | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 492.84 per share. | 13 Feb 2023 | 573 | 35,575 (0%) | 0% | 492.8 | 282,398 | Common Stock |
| Thomas E. Roos | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 496.49 per share. | 13 Feb 2023 | 402 | 35,002 (0%) | 0% | 496.5 | 199,589 | Common Stock |
| Thomas E. Roos | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 495.69 per share. | 13 Feb 2023 | 798 | 35,405 (0%) | 0% | 495.7 | 395,558 | Common Stock |
| John F. Rex | EVP Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 493.33 per share. | 13 Feb 2023 | 640 | 142,476 (0%) | 0% | 493.3 | 315,730 | Common Stock |
| John F. Rex | EVP Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 492.99 per share. | 13 Feb 2023 | 1,367 | 143,117 (0%) | 0% | 493.0 | 673,914 | Common Stock |
| John F. Rex | EVP Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 495.62 per share. | 13 Feb 2023 | 831 | 141,749 (0%) | 0% | 495.6 | 411,862 | Common Stock |
| John F. Rex | EVP Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 495.55 per share. | 13 Feb 2023 | 1,774 | 142,581 (0%) | 0% | 495.6 | 879,107 | Common Stock |
| Brian R. Thompson | CEO, UnitedHealthcare | Grant, award, or other acquisition of securities at price $ 495.51 per share. | 13 Feb 2023 | 1,079 | 25,902 (0%) | 0% | 495.5 | 534,651 | Common Stock |
| Brian R. Thompson | CEO, UnitedHealthcare | Payment of exercise price or tax liability using portion of securities received from the company at price $ 496.04 per share. | 13 Feb 2023 | 334 | 25,568 (0%) | 0% | 496.0 | 165,678 | Common Stock |
| Brian R. Thompson | CEO, UnitedHealthcare | Grant, award, or other acquisition of securities at price $ 493.06 per share. | 13 Feb 2023 | 933 | 26,501 (0%) | 0% | 493.1 | 460,021 | Common Stock |
| Brian R. Thompson | CEO, UnitedHealthcare | Payment of exercise price or tax liability using portion of securities received from the company at price $ 493.92 per share. | 13 Feb 2023 | 285 | 26,216 (0%) | 0% | 493.9 | 140,767 | Common Stock |
| Michele J. Hooper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 109 | 37,802 (0%) | 0% | 0 | Common Stock | |
| Paul R. Garcia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 109 | 2,972 (0%) | 0% | 0 | Common Stock | |
| Paul R. Garcia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 61 | 3,033 (0%) | 0% | 0 | Common Stock | |
| Timothy Patrick Flynn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 181 | 8,684 (0%) | 0% | 0 | Common Stock | |
| John H. Noseworthy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 181 | 3,937 (0%) | 0% | 0 | Common Stock | |
| Valerie Montgomery Rice | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 181 | 4,427 (0%) | 0% | 0 | Common Stock | |
| Kristen L. Gil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 43 | 153 (0%) | 0% | 0 | Common Stock | |
| Kristen L. Gil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 43 | 153 (0%) | 0% | 0 | Common Stock | |
| F. William McNabb | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 185 | 11,748 (0%) | 0% | 0 | Common Stock | |
| Stephen J. Hemsley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2022 | 275 | 541,890 (0%) | 0% | 0 | Common Stock | |
| Stephen J. Hemsley | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 20 Dec 2022 | 10,500 | 541,615 (0%) | 0% | 0 | Common Stock | |
| Erin L. McSweeney | EVP Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2022 | 25 | 8,761 (0%) | 0% | 0 | Common Stock | |
| Michele J. Hooper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2022 | 105 | 37,693 (0%) | 0% | 0 | Common Stock | |
| Paul R. Garcia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2022 | 2 | 2,863 (0%) | 0% | 0 | Common Stock | |
| Stephen J. Hemsley | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 13 Dec 2022 | 3,700 | 552,115 (0%) | 0% | 0 | Common Stock | |
| Stephen J. Hemsley | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 13 Dec 2022 | 27,000 | 555,815 (0%) | 0% | 0 | Common Stock | |
| Stephen J. Hemsley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2022 | 23 | 582,815 (0%) | 0% | 0 | Common Stock | |
| Andrew P. Witty | Director, CEO, UHG | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2022 | 103 | 76,441 (0%) | 0% | 0 | Common Stock | |
| Rupert Mark Boden Bondy | EVP & Chief Legal Officer | 13 Dec 2022 | 7 | 2,317 (0%) | 0% | 0 | Common Stock | ||
| Timothy Patrick Flynn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2022 | 22 | 8,503 (0%) | 0% | 0 | Common Stock | |
| Dirk C. McMahon | Pres. & COO, UHG & CEO, UHC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 539.87 per share. | 13 Dec 2022 | 285 | 49,937 (0%) | 0% | 539.9 | 153,864 | Common Stock |